BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 1,720 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average trading volume of 21 shares, the short-interest ratio is presently 81.9 days.
BICO Group AB (publ) Stock Performance
BICO Group AB (publ) stock opened at C$1.76 on Tuesday. The business’s 50-day simple moving average is C$2.14 and its 200 day simple moving average is C$2.09. BICO Group AB has a 12-month low of C$1.76 and a 12-month high of C$3.95.
About BICO Group AB (publ)
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
See Also
- Five stocks we like better than BICO Group AB (publ)
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
